Literature DB >> 2530579

Two high-affinity interleukin 1 receptors represent separate gene products.

R Chizzonite1, T Truitt, P L Kilian, A S Stern, P Nunes, K P Parker, K L Kaffka, A O Chua, D K Lugg, U Gubler.   

Abstract

Interleukin 1 (IL-1) is a polypeptide hormone that mediates a broad range of biological activities and interacts with surface receptors on numerous cell types. Equilibrium binding studies have identified a class of IL-1 receptors on T cells, fibroblasts, and epithelial cells that have 2- to 5-fold higher affinity than the receptors on bone marrow cells, pre-B cells, and macrophage cell lines. Affinity cross-linking with human 125I-labeled IL-1 alpha (125I-IL-1 alpha) labels an approximately 100-kDa protein on T cells and fibroblasts and an approximately 80-kDa protein on pre-B cells and macrophage cell lines. Monoclonal and polyclonal antibodies specific for the IL-1 receptor on T cells and fibroblasts block human 125I-IL-1 alpha binding to T cells, fibroblasts, and epithelial cells but cannot block IL-1 binding to bone marrow cells, pre-B cells, and macrophages. These antibodies immunoprecipitate the IL-1 receptor-human 125I-IL-1 alpha complex from T cells and fibroblasts but not from pre-B cells and macrophage cell lines. An S1 nuclease protection assay demonstrated that T cells and fibroblasts contain identical IL-1 receptor mRNA but that pre-B cells and macrophages do not contain this receptor mRNA. Taken together, the data demonstrate that mouse T cells, fibroblasts, and epithelial cells express an identical IL-1 receptor, whereas the IL-1 receptor on pre-B cells, macrophages, and bone marrow cells represents a different gene product.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2530579      PMCID: PMC298207          DOI: 10.1073/pnas.86.20.8029

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  32 in total

1.  Identification of IL-1 receptors on human monocytes.

Authors:  J Uhl; R C Newton; J G Giri; G Sandlin; R Horuk
Journal:  J Immunol       Date:  1989-03-01       Impact factor: 5.422

2.  Characterization of lymphocyte-activating factor (LAF) produced by a macrophage cell line, P388D1. II. Biochemical characterization of LAF induced by activated T cells and LPS.

Authors:  S B Mizel; J J Oppenheim; D L Rosentreich
Journal:  J Immunol       Date:  1978-05       Impact factor: 5.422

3.  Murine interleukin-1 receptor: differences in binding properties between fibroblastic and thymoma cells and evidence for a two-chain receptor model.

Authors:  T A Bird; A J Gearing; J Saklatvala
Journal:  FEBS Lett       Date:  1987-12-10       Impact factor: 4.124

4.  Murine interleukin 1 receptor. Direct identification by ligand blotting and purification to homogeneity of an interleukin 1-binding glycoprotein.

Authors:  T A Bird; A J Gearing; J Saklatvala
Journal:  J Biol Chem       Date:  1988-08-25       Impact factor: 5.157

5.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

6.  cDNA expression cloning of the IL-1 receptor, a member of the immunoglobulin superfamily.

Authors:  J E Sims; C J March; D Cosman; M B Widmer; H R MacDonald; C J McMahan; C E Grubin; J M Wignall; J L Jackson; S M Call
Journal:  Science       Date:  1988-07-29       Impact factor: 47.728

7.  Cholecystokinin mRNA in porcine cerebellum.

Authors:  U Gubler; A O Chua; D Young; Z W Fan; J Eng
Journal:  J Biol Chem       Date:  1987-11-05       Impact factor: 5.157

8.  Regulation of hemopoiesis in myelosuppressed mice by human recombinant IL-1 alpha.

Authors:  W R Benjamin; N S Tare; T J Hayes; J M Becker; T D Anderson
Journal:  J Immunol       Date:  1989-02-01       Impact factor: 5.422

9.  Presence of IL-1 receptors on human and murine neutrophils. Relevance to IL-1-mediated effects in inflammation.

Authors:  K P Parker; W R Benjamin; K L Kaffka; P L Kilian
Journal:  J Immunol       Date:  1989-01-15       Impact factor: 5.422

10.  Stimulation of rheumatoid synovial cell collagenase and prostaglandin production by partially purified lymphocyte-activating factor (interleukin 1).

Authors:  S B Mizel; J M Dayer; S M Krane; S E Mergenhagen
Journal:  Proc Natl Acad Sci U S A       Date:  1981-04       Impact factor: 11.205

View more
  54 in total

1.  Is there a causal role for IL-1 in postmenopausal bone loss?

Authors:  R Pacifici
Journal:  Calcif Tissue Int       Date:  1992-04       Impact factor: 4.333

2.  Cytokine-dependent but acquired immunity-independent arthritis caused by DNA escaped from degradation.

Authors:  Kohki Kawane; Hiromi Tanaka; Yusuke Kitahara; Shin Shimaoka; Shigekazu Nagata
Journal:  Proc Natl Acad Sci U S A       Date:  2010-10-25       Impact factor: 11.205

3.  Evidence that responses of articular chondrocytes to interleukin-1 and basic fibroblast growth factor are not mediated by protein kinase C.

Authors:  K I Hulkower; H I Georgescu; C H Evans
Journal:  Biochem J       Date:  1991-05-15       Impact factor: 3.857

4.  An interleukin-1 receptor antagonist blocks lipopolysaccharide-induced colony-stimulating factor production and early endotoxin tolerance.

Authors:  B E Henricson; R Neta; S N Vogel
Journal:  Infect Immun       Date:  1991-03       Impact factor: 3.441

5.  Specific inhibition of interleukin 3 bioactivity by a monoclonal antibody reactive with hematopoietic progenitor cells.

Authors:  P D Emanuel; S C Peiper; Z Chen; D C Sheng; K S Zuckerman
Journal:  Proc Natl Acad Sci U S A       Date:  1990-06       Impact factor: 11.205

6.  Mouse interleukin-1 receptor antagonist induced by Actinobacillus actinomycetemcomitans lipopolysaccharide blocks the effects of interleukin-1 on bone resorption and osteoclast-like cell formation.

Authors:  T Nishihara; Y Ohsaki; N Ueda; N Saito; G R Mundy
Journal:  Infect Immun       Date:  1994-02       Impact factor: 3.441

7.  Comparison of peripheral blood leukocyte kinetics after live Escherichia coli, endotoxin, or interleukin-1 alpha administration. Studies using a novel interleukin-1 receptor antagonist.

Authors:  A S Hawes; E Fischer; M A Marano; K J Van Zee; C S Rock; S F Lowry; S E Calvano; L L Moldawer
Journal:  Ann Surg       Date:  1993-07       Impact factor: 12.969

8.  Interleukin 1 signaling occurs exclusively via the type I receptor.

Authors:  J E Sims; M A Gayle; J L Slack; M R Alderson; T A Bird; J G Giri; F Colotta; F Re; A Mantovani; K Shanebeck
Journal:  Proc Natl Acad Sci U S A       Date:  1993-07-01       Impact factor: 11.205

9.  Differential interleukin-1 receptor antagonism on pancreatic beta and alpha cells. Studies in rodent and human islets and in normal rats.

Authors:  U Zumsteg; J I Reimers; F Pociot; L Mørch; S Helqvist; M Brendel; R Alejandro; T Mandrup-Poulsen; C A Dinarello; J Nerup
Journal:  Diabetologia       Date:  1993-08       Impact factor: 10.122

10.  Evidence that interleukin-1 mediates its effects on bone resorption via the 80 kilodalton interleukin-1 receptor.

Authors:  I R Garrett; T A Guise; L F Bonewald; R Chizzonite; G R Mundy
Journal:  Calcif Tissue Int       Date:  1993-06       Impact factor: 4.333

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.